Skip to main content
Premium Trial:

Request an Annual Quote

Tekmira Legacy Drug Launched in US by Licensee Spectrum

Premium

Tekmira Pharmaceuticals this week announced that Spectrum Pharmaceuticals, which licensed Tekmira's non-RNAi cancer drug Marqibo earlier this year, has launched the product in the US.

The drug is a version of the approved chemotherapeutic vincristine formulated with Tekmira's liposome technology. It is a legacy product developed by Tekmira prior to its becoming a pure-play RNAi drug developer, and was later licensed to Talon Therapeutics. Talon was acquired by Spectrum in July.

Tekmira stands to receive royalties on sales of Marqibo.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.